ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers
Disease control OngoingThis study tests two experimental drugs, ERAS-007 and ERAS-601, in people with advanced solid tumors that have not responded to standard treatments. The drugs are taken orally and aim to block signals that help cancer grow. The trial will first find safe doses and then check if t…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New cancer drug IDE161 enters human testing
Disease control OngoingThis early-stage trial is testing a new drug called IDE161, alone or with the immunotherapy pembrolizumab, in adults with advanced solid tumors (like breast, ovarian, prostate, or lung cancer). The main goals are to check safety, find the right dose, and get a first look at wheth…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a new drug called KGX101, alone or with another drug (envafolimab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the right dose, and see how the body processes the d…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Kangabio AUSTRALIA LTD PTY • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called ERAS-601, alone or with other cancer treatments, in adults with advanced solid tumors that have not responded to standard therapies. The main goals are to find safe doses and check for side effects. About 90 participants will take pa…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo targets tough cancers with RAS mutation
Disease control OngoingThis early-stage trial is testing whether a combination of two drugs, naporafenib and trametinib, can shrink or control advanced solid tumors that have a specific genetic change called RAS Q61X. About 86 people whose cancer has not responded to standard treatments will receive th…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New cancer drug WTX-330 enters human testing for advanced tumors
Disease control OngoingThis study tests an experimental drug called WTX-330 in 100 adults with advanced solid tumors or non-Hodgkin lymphoma that have not responded to standard treatments. The trial has two parts: first, finding the safest dose and schedule, then expanding to see how well the drug work…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Werewolf Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC